Scott Eric Plevy

机构：Protagonist Therapeutics (United States), Janssen (United States)

发表论文 249 篇 · 总被引 13603 次 · h-index 60

代表论文

Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease (2019 · Cell Host & Microbe · 被引 500)
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis (2020 · Gastroenterology · 被引 246)
Gut microbiota density influences host physiology and is shaped by host and microbial factors (2019 · eLife · 被引 187)
Symbionts exploit complex signaling to educate the immune system (2019 · Proceedings of the National Academy of Sciences · 被引 132)
Challenges in IBD Research: Environmental Triggers (2019 · Inflammatory Bowel Diseases · 被引 94)
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease (2022 · Gastroenterology · 被引 75)